Compare AMRC & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRC | PAHC |
|---|---|---|
| Founded | 2000 | 1946 |
| Country | United States | United States |
| Employees | N/A | 2475 |
| Industry | Engineering & Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | 2010 | 2014 |
| Metric | AMRC | PAHC |
|---|---|---|
| Price | $26.82 | $31.84 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 4 |
| Target Price | $37.88 | ★ $41.25 |
| AVG Volume (30 Days) | ★ 569.5K | 286.8K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.91% |
| EPS Growth | N/A | ★ 1883.33 |
| EPS | N/A | ★ 1.90 |
| Revenue | ★ $1,769,928,000.00 | $833,350,000.00 |
| Revenue This Year | $10.71 | $17.03 |
| Revenue Next Year | $9.07 | $3.82 |
| P/E Ratio | ★ N/A | $16.75 |
| Revenue Growth | ★ 28.76 | 4.12 |
| 52 Week Low | $14.88 | $25.33 |
| 52 Week High | $44.93 | $60.08 |
| Indicator | AMRC | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 40.82 | 40.32 |
| Support Level | $24.44 | $28.25 |
| Resistance Level | $27.25 | $34.49 |
| Average True Range (ATR) | 1.67 | 1.28 |
| MACD | -0.20 | 0.62 |
| Stochastic Oscillator | 32.62 | 32.58 |
Ameresco Inc is an energy infrastructure solutions provider dedicated to helping customers reduce costs, enhance resilience, and decarbonize to net zero in the energy transition. Its comprehensive portfolio includes implementing smart energy efficiency solutions, upgrading aging infrastructure, and developing, constructing, and operating distributed energy resources. Its solutions range from upgrades to facility's energy infrastructure to the development, construction and operation of renewable energy plants combined with tailored financial solutions. Its segments include North America Regions, U.S. Federal, Renewable Fuels, Europe, and Others. The majority of the revenue is derived from North America Regions segment.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.